A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancer.

ESMO Open · 2026 · PMC13040913 · PMID 41895875

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Herein, only ER-Predict (ΔLR χ 2 = 3.42, P = 0.063) and R-Oncotype DX (ΔLR χ 2 = 3.56, P = 0.059) showed a trend for additional prognostic value in T2/N0 tumors compared with T1/N0 cases.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.